| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Dogwood Therapeutics, Inc.
13D/A
DWTX · 92829J203
|
75.2% |
10/27/2026
Event 10/26/2026
|
||||
| Sealbond Limited | 67.8% | |||||
| CK Life Sciences Int'l., (Holdings) Inc. | 75.2% | |||||
| Conjoint Inc. | 7.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.